TLDR
- Wellgistics adopts XRP with a $50M credit line.
- XRP to power payments and credit lines.
- Faster, cheaper than wire and ACH.
- XRP Ledger aids compliance and audits.
- Aligns with rising institutional XRP use.
Florida-based pharmaceutical distribution company Wellgistics Health, Inc. (NASDAQ: WGRX) has announced a significant initiative to adopt XRP, a blockchain-based digital asset, as part of its treasury reserves and payments infrastructure. The company has secured a $50 million equity line of credit (ELOC) from LDA Capital to support the implementation of XRP-based financial operations.
JUST IN: 🇺🇸 Pharmaceutical distributor, Wellgistics Health, set to integrate $XRP as a treasury and payments asset in $50 million financing deal. pic.twitter.com/PtyN7Z6mtg
— Whale Insider (@WhaleInsider) May 9, 2025
The move positions Wellgistics as one of the first publicly traded U.S. healthcare firms to incorporate XRP in this capacity. The firm plans to use the XRP to support real-time payment settlements, vendor payouts, and the issuance of credit lines within its pharmaceutical distribution network. The adoption is expected to help streamline payment operations, reduce costs, and increase transaction transparency.
According to the company, XRP can settle transactions in 3–5 seconds and low cost of $0.0002 per transaction. These make it well-suited to replace traditional banking methods such as ACH or wire transfers, which often take 1–3 days and cost between $10 and $30 per transfer. All XRP transactions will be recorded on the XRP Ledger, offering an immutable record for compliance, rebate tracking, and auditing.
Application of XRP Across Healthcare Financial Operations
Wellgistics aims to leverage XRP for several use cases across its healthcare ecosystem. These include real-time settlements between pharmacies, suppliers, and manufacturers. The automation of performance-based rebates and the provision of XRP-backed credit lines boost liquidity for independent pharmacies. Additionally, the firm plans to use the system for global vendor payouts, utilizing XRP’s low-cost foreign exchange capabilities.
The company sees XRP’s blockchain infrastructure as a solution to eliminate traditional financial bottlenecks that have long challenged the pharmaceutical supply chain. Wellgistics intends to create a transparent healthcare financial ecosystem by enabling near-instantaneous transactions and reducing dependency on banking intermediaries.
The XRP Ledger supports reporting under the Drug Supply Chain Security Act (DSCSA) and pricing validation measures. This infrastructure is designed to embed audibility into the firm’s operations, which is particularly important in the regulated healthcare sector.
Market Trends and Industry Positioning
Wellgistics’ announcement comes as XRP continues to gain traction in institutional finance. Several developments highlight growing interest in the digital asset, CME Group’s plans to launch XRP futures in May 2025 and Mastercard identifying XRP as a bridge currency for cross-border payments. Additionally, Ripple, the blockchain company behind XRP, has expanded its presence with a $1.25 billion acquisition of brokerage firm Hidden Road and obtained regulatory licensing in Dubai.
Through its integration of XRP, Wellgistics seeks to align itself with this broader trend of institutional adoption. The company stated that its blockchain-enabled financial platform intended to enable leaner and faster operations compared to legacy financial systems in healthcare. CEO Brian Norton emphasized that the company focuses on building a flexible and efficient infrastructure rather than maintaining traditional operational models. The initiative marks a notable step in the ongoing convergence of healthcare and digital finance.
Source: CoinMarketCap
The XRP price shows a steady upward trend over the past 24 hours, increasing by 5.77% to reach $2.34. Trading volume surged by 48.50%, indicating heightened investor activity and interest. Despite a slight dip toward the end, the overall momentum remains positive, supported by a strong market cap growth of 5.85%.
